Recently, Shanghai Metash Instrument Co.,Ltd. has taken a significant step to integrate into Haier Group’s Healthcare Industry Ecosystem. Based on the consensus of the development concept of both sides and the common optimistic potentials for future growth, Metash and Haier Biomedical achieved ecological integration.
This integration can be described as alliance between two giants. Haier Biomedical officially entered the analytical instrument industry, and Metash can also grow faster and stronger with the help of Haier’s strength in market competition, ecological construction, brand management and capital support.
In the future, Metash will be an independent business segment in the field of Haier Biomedical in analytical instruments filed, continue to focus on users, adhere to independent innovation and constantly enrich and improve spectral analysis and water analysis.
Since its establishment, Metash has adhered to the corporate spirit of “drinking water and remembering the source, striving for excellence through analysis.” The company is dedicated to technological innovation and deep industry engagement, continuously overcoming technical barriers and upgrading products. Metash has received numerous honors, including “Specialized and Sophisticated Enterprise”, “High-tech Enterprise”, “Enterprise Technology Center in Songjiang District ” and “Patent Pilot Enterprise in Songjiang District ”. It holds over 70 national patents and software copyrights. Currently, Metash has developed a range of products such as UV-Vis spectrophotometers, Microwave digestion systems, TOC analyzers, Atomic absorption spectrophotometers, Centrifuges, and Nano spectrophotometer. These products are at the forefront of domestic analytical instruments in fields such as food safety, environmental monitoring, chemical engineering, and scientific research. Additionally, Metash has established 30 sales and service centers domestically, ensuring localized after-sales service. Meanwhile, Metash’s products have been exported to over 90 countries and regions, earning global users’ acclaim.
Haier Biomedical is a global life science and medical innovation digital scenario solution provider. Aiming to create the best user experience, the company serves life science users such as pharmaceutical companies, universities, and research institutions, as well as healthcare users including hospitals, disease control centers, blood banks, and primary public health organizations. It offers comprehensive digital scenario solutions represented by smart laboratories, digital hospitals, smart public health, and intelligent blood use. Upholding the vision of “Making Life Better,” Haier Biomedical is committed to technological innovation and leading industrial transformation. By the end of 2023, the company had established six major technology platforms, accumulated 1,321 patents, 296 software copyrights, and led or participated in the formulation of 40 international, national, industry, and group standards and technical specifications. It has received over 35 provincial-level or higher scientific and technological awards, with 32 achievements recognized as internationally leading. Currently, the company’s products and solutions serve more than 150 countries and regions worldwide.
At this new starting point, Metash will collaborate with Haier Biomedical, taking user needs as a foundation to drive technological innovation and product upgrades. By exploring new market opportunities and trends together, they will leverage their resource advantages to achieve breakthroughs in technological innovation, product development, and market expansion, providing global users with more precise and comprehensive one-stop analytical instrument solutions, and promoting the intelligent and efficient development of laboratory equipment.
Looking ahead, Metash Instruments will forge ahead with high spirits, collaborating with Haier Biomedical to grasp market dynamics and quickly respond to industry changes. We will fully support people in exploring the unknown, contributing to the prosperity and development of the industry.
Together, we will create a better future!
